Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Asthma
Location: United States, FL
Do you, or does your child have asthma?
This study is a randomized, double-blind, stratified, parallel-group, multicenter study, 26 weeks in duration, that is designed to evaluate the non-inferiority of fluticasone propionate/salmeterol combination versus fluticasone propionate on the composite endpoint of serious asthma outcomes (asthma-related hospitalization, endotracheal intubation, and death) in subjects with asthma. There is no placebo in this clinical research study. There will be no blood draws. Qualified study participants will receive asthma medication and study related medical care for their asthma at no charge. Compensation may be provided for time and travel.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 182056
Date Last Changed:
July 18, 2013
Jeffrey Hirschfield, M.D., Principal InvestigatorSCORE Physician Alliance6499 38Th Avenue North, Suite A-2St. Petersburg, FL 33710Phone: 727-381-4305
SCORE Physician Alliance
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2016 CenterWatch.